; (ii) enabling such users to access any updates to information collected by the program in as close to real-time as possible; (iii) providing for a mechanism for the program to automatically flag any potential misuse or abuse of controlled substances and any detection of inappropriate prescribing practices relating to such substances; (iv) enhancing interoperability between the program and any electronic health records system, including by integrating the use of electronic health records into the program for purposes of improving clinical decisionmaking; (v) continually updating program capabilities to respond to technological innovation for purposes of appropriately addressing a controlled substance overdose epidemic as such epidemic may occur and evolve; (vi) facilitating data sharing between the program and the prescription drug monitoring programs of neighboring States; and (vii) meeting the purpose of the program established under section 399O, as described in section 399O(a). (B) Achieving community or health system interventions through activities such as— (i) establishing or improving controlled substances prescribing interventions for insurers and health systems; (ii) enhancing the use of evidence-based controlled substances prescribing guidelines across sectors and health care settings